Philipp Grob

791 total citations
15 papers, 555 citations indexed

About

Philipp Grob is a scholar working on Microbiology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Philipp Grob has authored 15 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Microbiology, 5 papers in Epidemiology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Philipp Grob's work include Reproductive tract infections research (6 papers), Urinary Tract Infections Management (4 papers) and Menopause: Health Impacts and Treatments (4 papers). Philipp Grob is often cited by papers focused on Reproductive tract infections research (6 papers), Urinary Tract Infections Management (4 papers) and Menopause: Health Impacts and Treatments (4 papers). Philipp Grob collaborates with scholars based in Germany, Belgium and France. Philipp Grob's co-authors include V. Prasauskas, Dominique Brassart, Alain L. Servin, Fabrice Atassi, Olaf Ortmann, Gilbert Donders, Gert Bellen, Stefan Buchholz, Patrick Neven and Anneleen Lintermans and has published in prestigious journals such as BJOG An International Journal of Obstetrics & Gynaecology, Journal of Applied Microbiology and Breast Cancer Research and Treatment.

In The Last Decade

Philipp Grob

15 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philipp Grob Germany	12	256	189	162	123	104	15	555
Avner Leshem Israel	8	180 0.7×	182 1.0×	307 1.9×	12 0.1×	44 0.4×	11	629
Greg T. Spear United States	9	235 0.9×	170 0.9×	195 1.2×	10 0.1×	39 0.4×	14	582
Silver Türk Estonia	12	124 0.5×	116 0.6×	87 0.5×	27 0.2×	7 0.1×	18	530
Kateryna Ruban Belgium	8	290 1.1×	210 1.1×	72 0.4×	32 0.3×	15 0.1×	15	397
Jeong Don Chae South Korea	10	90 0.4×	115 0.6×	125 0.8×	18 0.1×	19 0.2×	25	368
P D Simmons United Kingdom	13	146 0.6×	227 1.2×	46 0.3×	46 0.4×	11 0.1×	27	473
Bianca M. Coleman United States	14	86 0.3×	265 1.4×	190 1.2×	6 0.0×	44 0.4×	16	781
A D Dwarakanath United Kingdom	11	28 0.1×	141 0.7×	224 1.4×	12 0.1×	59 0.6×	15	578
David W. Lawellin United States	10	86 0.3×	130 0.7×	72 0.4×	11 0.1×	13 0.1×	13	475
Amalia Vences-Velázquez Mexico	12	33 0.1×	110 0.6×	116 0.7×	22 0.2×	21 0.2×	34	351

Countries citing papers authored by Philipp Grob

Since Specialization

Citations

This map shows the geographic impact of Philipp Grob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Grob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Grob more than expected).

Fields of papers citing papers by Philipp Grob

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Grob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Grob. The network helps show where Philipp Grob may publish in the future.

Co-authorship network of co-authors of Philipp Grob

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Grob. A scholar is included among the top collaborators of Philipp Grob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Grob. Philipp Grob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Grob, Philipp, et al.. (2024). Efficacy of Dequalinium Chloride vs Metronidazole for the Treatment of Bacterial Vaginosis. JAMA Network Open. 7(5). e248661–e248661. 3 indexed citations

Mueck, A. O., Xiangyan Ruan, V. Prasauskas, Philipp Grob, & Olaf Ortmann. (2018). Treatment of vaginal atrophy with estriol and lactobacilli combination: a clinical review. Climacteric. 21(2). 140–147. 32 indexed citations

Donders, Gilbert, Gert Bellen, Patrick Neven, et al.. (2015). Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors. European Journal of Clinical Microbiology & Infectious Diseases. 34(10). 2023–2028. 27 indexed citations

Mendling, Werner, E. R. Weissenbacher, Stefan Gerber, V. Prasauskas, & Philipp Grob. (2015). Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review. Archives of Gynecology and Obstetrics. 293(3). 469–484. 56 indexed citations

Donders, Gilbert, Patrick Neven, Anneleen Lintermans, et al.. (2014). Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor®) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study. Breast Cancer Research and Treatment. 145(2). 371–379. 77 indexed citations

Buchholz, Stefan, Anneleen Lintermans, Gert Bellen, et al.. (2014). Vaginal estriol–lactobacilli combination and quality of life in endocrine-treated breast cancer. Climacteric. 18(2). 252–259. 31 indexed citations

Jaisamrarn, Unnop, Surang Triratanachat, Sukanya Chaikittisilpa, et al.. (2013). Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy. Climacteric. 16(3). 347–355. 53 indexed citations

Santiago, Guido Lopes dos Santos, et al.. (2012). Susceptibility testing of Atopobium vaginae for dequalinium chloride. BMC Research Notes. 5(1). 151–151. 13 indexed citations

Grob, Philipp, et al.. (2011). Antimicrobial Activity of Dequalinium Chloride against Leading Germs of Vaginal Infections. Arzneimittelforschung. 52(9). 699–705. 25 indexed citations

10.

Atassi, Fabrice, et al.. (2006). In vitro antibacterial activity of Lactobacillus helveticus strain KS300 against diarrhoeagenic, uropathogenic and vaginosis-associated bacteria. Journal of Applied Microbiology. 101(3). 647–654. 36 indexed citations

11.

Atassi, Fabrice, et al.. (2006). Lactobacillusstrains isolated from the vaginal microbiota of healthy women inhibitPrevotella biviaandGardnerella vaginalisin coculture and cell culture. FEMS Immunology & Medical Microbiology. 48(3). 424–432. 113 indexed citations

12.

Atassi, Fabrice, et al.. (2006). VaginalLactobacillusisolates inhibit uropathogenicEscherichia coli. FEMS Microbiology Letters. 257(1). 132–138. 22 indexed citations

13.

Özkinay, Erdinç, et al.. (2005). The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG An International Journal of Obstetrics & Gynaecology. 112(2). 234–240. 62 indexed citations

14.

Om, Hess, et al.. (1977). [Prognostic evaluation of congestive cardiomyopathy (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 66(7). 351–60. 4 indexed citations

15.

Om, Hess, et al.. (1977). [Transvenous endomyocardial biopsy in the assessment of congestive cardiomyopathy].. PubMed. 107(9). 293–300. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact